Alen Sam Saji Biao Yang Wan Ting Hou Xia Liu Qiu Ping Ren Yuan Feng Wei Yu Zu Zhang Xi Yang
10.3389/fonc.2023.1090580
Front Oncol
2023 Jan 30;13:1090580.
ebv cholangiocarcinoma liver lymphoepithelioma-like carcinoma nivolumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/36865802/
Case Reports
PMC9971717
36865802
Combined NK-CIK and PD-1 inhibitor (nivolumab), an effective immunotherapy for treating intrahepatic lymphoepithelioma-like cholangiocarcinoma unassociated with EBV infection: Two case reports and a literature review
2023